AskMayoExpert. Systemic mastocytosis. Mayo Clinic; 2024.
Gulen T. Management of mediator symptoms, allergy, and anaphylaxis in mastocytosis. Immunology and Allergy Clinics of North America. 2023; doi:10.1016/j.iac.2023.04.010.
Valent P, et al. World Health Organization classification and diagnosis of mastocytosis: Update 2023 and future perspectives. Immunology and Allergy Clinics of North America. 2023; doi:10.1016/j.iac.2023.04.011.
Farmer I, et al. Systemic mastocytosis: State of the art. Current Hematologic Malignancy Reports. 2024; doi:10.1007/s11899-024-00737-8.
Mastocytosis and mast cell activation syndrome. Merck Manual Professional Version. https://www.merckmanuals.com/professional/immunology-allergic-disorders/allergic-autoimmune-and-other-hypersensitivity-disorders/mastocytosis-and-mast-cell-activation-syndrome. Accessed April 1, 2025.
Pardanani A. Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management. American Journal of Hematology. 2023; doi:10.1002/ajh.26962.
Pardanani A, et al. Advanced systemic mastocytosis — Revised classification, new drugs and how we treat. British Journal of Haematology. 2024; doi:10.1111/bjh.19245.
Radia DH, et al. Update on diagnostic approaches and therapeutic strategies in systemic mastocytosis. Best Practice & Research Clinical Haematology. 2022; doi:10.1016/j.beha.2022.101380.
Medical review (expert opinion). Mayo Clinic. April 17, 2025.